• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR ONYX AVM; AGENT, INJECTABLE, EMBOLIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR ONYX AVM; AGENT, INJECTABLE, EMBOLIC Back to Search Results
Model Number 105-7000-060
Device Problem Entrapment of Device (1212)
Patient Problem Foreign Body In Patient (2687)
Event Date 11/05/2014
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device will not been returned for analysis as it was implanted; therefore the complaint could not be determined.However, based on the reported information, user contributed to the catheter entrapment.In this event, it was reported that there was approximately 28mm of onyx reflux surrounding the catheter tip.Per onyx les instruction for use: "do not allow more than 1cm of onyx les reflux back over catheter tip.Angioarchitecture, vasospasm, excessive onyx reflux or prolonged injection time may result in difficult catheter removal and catheter entrapment.Excessive force to remove an entrapped catheter may cause serious intracranial hemorrhage.The long term effects of an entrapped catheter that is left in a patient is unknown, but could potentially include clot formation, infection, or catheter migration.".
 
Event Description
Medtronic received information that a catheter became stuck during an onyx embolization procedure.The patient underwent onyx embolization procedure of a type iia+b dural arteriovenous fistula (davf) located in the right petrosal sinus.The vessel was moderately tortuous.During the procedure, the physician paused several times for about 2-3 minutes each.It was reported that there was 28 mm onyx reflux.A competitor's catheter became stuck and broke during removal leaving approximately 30-60cm of the catheter in the patient.Based on the procedure note, complete occlusion of the nidus of the malformation and its venous drainage was achieved by injection of a total of 0.8ml of onyx in the nidus.The patient's current status is mrs1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ONYX AVM
Type of Device
AGENT, INJECTABLE, EMBOLIC
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3 NEUROVA
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9498373700
MDR Report Key5365564
MDR Text Key35917584
Report Number2029214-2016-00027
Device Sequence Number1
Product Code MFE
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
P030004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,s
Reporter Occupation Physician
Type of Report Initial
Report Date 12/18/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/29/2017
Device Model Number105-7000-060
Device Lot Number9966572
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/18/2015
Initial Date FDA Received01/13/2016
Date Device Manufactured09/11/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age00031 YR
Patient Weight80
-
-